Amazon S3 on MSN
WHO supports weight loss drugs for tackling obesity crisis
Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...
Q. I developed severe depression while taking Repatha, the injectable cholesterol-lowering drug. It took me a horrible nine months to realize the drug was making me suicidal. If I wasn’t sleeping, I ...
Emma Kleck has been totally dependent on insulin, the lifesaving medication for people living with diabetes, for 25 years.
The Indian judiciary did well not to let Novo Nordisk extend its exclusive right to sell semaglutide, marketed as Ozempic and ...
Since their introduction, GLP-1 medications have rapidly gained popularity for their effectiveness in helping people manage ...
Doctronic reports that AI healthcare visits primarily involve managing chronic conditions like thyroid disorders, diabetes, ...
For more than two years it had the entirety of the market for weight-loss drugs to itself. By 2023 sales of Wegovy had ...
People who brought their blood glucose down to a normal level had a lower risk of death from heart disease or hospitalization ...
A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly ...
The new CalRx insulin will hit the market in January at $55 a month, part of a broader state effort to rein in drug costs.
Scientists have discovered that semaglutide, the active ingredient in drugs like Ozempic and Wegovy, offers a new benefit for ...
Sanofi sees continued growth and strong financials despite a pipeline setback. Click for this updated look at SNY stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results